Use of antiarrhythmic drugs in elderly patients

Journal of Geriatric Cardiology

Volumn 8, Issue 3, 2011, Pages 184-194

  Lee, Hon Chi ^a   Huang, Kristin T L ^b   Shen, Win Kuang ^c  

^a MAYO CLINIC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Aging; Antiarrhythmic drugs; Cardiac electrophysiology; Ion channels; Pharmacodynamics; Pharmacokinetics; Polypharmacy

Indexed keywords

ALCOHOL; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450; DIAZEPAM; DIGOXIN; DISOPYRAMIDE; DOFETILIDE; DRONEDARONE; ENCAINIDE; FLECAINIDE; GLUCOCORTICOID; LIDOCAINE; METOPROLOL; MEXILETINE; PHENOBARBITAL; PHENYTOIN; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; RIFAMPICIN; SOTALOL; VERAPAMIL; WARFARIN;

AGING; ANTICHOLINERGIC EFFECT; ARTIFICIAL HEART PACEMAKER; BLEEDING; BRADYCARDIA; BRONCHOSPASM; CALCIUM CELL LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLETE HEART BLOCK; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONSTIPATION; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; ELECTROCARDIOGRAM; FALLING; FIRST DEGREE ATRIOVENTRICULAR BLOCK; FIRST PASS EFFECT; GERIATRIC CARE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE VARIABILITY; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; MAXIMUM PLASMA CONCENTRATION; ORTHOSTATIC HYPOTENSION; POLYPHARMACY; POTASSIUM CURRENT; PR INTERVAL; PROSTATE HYPERTROPHY; PROSTATISM; QT PROLONGATION; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SHORT QT INTERVAL; SIDE EFFECT; SINUS BRADYCARDIA; SINUS NODE DYSFUNCTION; SODIUM CALCIUM EXCHANGE; STOMACH ACID SECRETION; STOMACH EMPTYING; SUDDEN DEATH; TIME TO MAXIMUM PLASMA CONCENTRATION; URINE RETENTION;

EID: 80053532113     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1263.2011.00184     Document Type: Conference Paper

References (103)

1. Day JC. Population projections of the United States, by age, sex, race, and hispanic origin: 1993 to 2050, U.S. Bureau of the Census, U.S. Government Printing Office, Current Population Reports; Washington DC, 1996; 25-1130.
2. DESA, World population prospect: The 2008 revision, population database; United Nations: New York, 2009.
3. Mittelmark MB, Psaty BM, Rautaharju PM, et al. Prevalence of cardiovascular diseases among older adults. The Cardiovascular health study. Am J Epidemiol 1993; 137: 311-317. (Pubitemid 23090465)
4. th Edition; Saunders, 2011; 1727-1756.
5. Fang MC, Chen J, Rich MW. Atrial fibrillation in the elderly. Am J Med 2007; 120: 481-487. (Pubitemid 46773017)
6. Buxton AE. Implantable cardioverter-defibrillators should be used routinely in the elderly. Am J Geriatr Cardiol 2006; 15: 361-364; quiz 365-366.
7. Kusumoto FM, Phillips R, Goldschlager N. Pacing therapy in the elderly. Am J Geriatr Cardiol 2002; 11: 305-316.
8. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375. (Pubitemid 32424106)
9. Chugh SS, Jui J, Gunson K, et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004; 44: 1268-1275. (Pubitemid 39208884)
10. Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis 2008; 51: 213-228.
11. Kaszala K, Kalahasty G, Ellenbogen KA. Cardiac pacing in the elderly. Am J Geriatr Cardiol 2006; 15: 77-81.
12. Samartin RC, Ferrer JM, De Carranza MJ, et al. Spanish pacemaker registry. 6th official report of the Spanish Society of Cardiology Working Group on Cardiac Pacing (2008). Rev Esp Cardiol 2009; 62: 1450-1463.
13. Joyner MJ. Not so fast: intrinsic heart rate vs. beta-adrenergic responsiveness in the aging human heart. J Appl Physiol 2008; 105: 3-4.
14. Christou DD, Seals DR. Decreased maximal heart rate with aging is related to reduced {beta}-adrenergic responsiveness but is largely explained by a reduction in intrinsic heart rate. J Appl Physiol 2008; 105: 24-29.
15. Fleg JL, Das DN, Wright J, et al. Age-associated changes in the components of atrioventricular conduction in apparently healthy volunteers. J Gerontol 1990; 45: M95-M100. (Pubitemid 20171155)
16. Miller WL, Ballman KV, Hodge DO, et al. Risk factor implications of incidentally discovered uncomplicated bundle branch block. Mayo Clin Proc 2005; 80:1585-1590. (Pubitemid 41747060)
17. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982; 81: 302-307. (Pubitemid 12191944)
18. Manolio TA, Furberg CD, Rautaharju PM, et al. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the cardiovascular health study. J Am Coll Cardiol 1994; 23: 916-925. (Pubitemid 24090878)
19. Mangoni AA, Kinirons MT, Swift CG, et al. Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis. Age Ageing 2003; 32: 326-331. (Pubitemid 36622239)
20. Jones PP, Christou DD, Jordan J, et al. Baroreflex buffering is reduced with age in healthy men. Circulation 2003; 107: 1770-1774. (Pubitemid 36418358)
21. Reardon M, Malik M. Changes in heart rate variability with age. Pacing Clin Electrophysiol 1996; 19(11Pt2): 1863-1866. (Pubitemid 26398467)
22. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The cardiovascular health study. CHS collaborative research group. Hypertension 1992; 19: 508-519.
23. Janczewski AM, Spurgeon HA, Lakatta EG. Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca2+ regulation. J Mol Cell Cardiol 2002; 34: 641-648. (Pubitemid 35222849)
24. Walker KE, Lakatta EG, Houser SR. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc Res 1993; 27: 1968-1977. (Pubitemid 23357341)
25. Baba S, Dun W, Hirose M, et al. Sodium current function in adult and aged canine atrial cells. Am J Physiol Heart Circ Physiol 2006; 291: H756-H761. (Pubitemid 44175082)
26. Josephson IR, Guia A, Stern MD, et al. Alterations in properties of L-type Ca channels in aging rat heart. J Mol Cell Cardiol 2002; 34: 297-308. (Pubitemid 37162422)
27. Dun W, Yagi T, Rosen MR, et al. Calcium and potassium currents in cells from adult and aged canine right atria. Cardiovasc Res 2003; 58: 526-534. (Pubitemid 36694438)
28. Jovanovic S, Jovanovic A. Sarcolemmal K (ATP) channels in ageing. Ageing Res Rev 2004; 3: 199-214.
29. Cerbai E, Barbieri M, Li Q, et al. Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovasc Res 1994; 28: 1180-1187. (Pubitemid 24264724)
30. Dun W, Boyden PA. Aged atria: electrical remodeling conducive to atrial fibrillation. J Interv Card Electrophysiol 2009; 25: 9-18.
31. Yanni J, Tellez JO, Sutyagin PV, et al. Structural remodelling of the sinoatrial node in obese old rats. J Mol Cell Cardiol 2010; 48: 653-662.
32. Jones SA, Boyett MR, Lancaster MK. Declining into failure: the age-dependent loss of the L-type calcium channel within the sinoatrial node. Circulation 2007; 115: 1183-1190. (Pubitemid 46594761)
33. Jones SA, Lancaster MK, Boyett MR. Ageing-related changes of connexins and conduction within the sinoatrial node. J Physiol 2004; 560: 429-437. (Pubitemid 39440105)
34. Monfredi O, Dobrzynski H, Mondal T, et al. The anatomy and physiology of the sinoatrial node - a contemporary review. Pacing Clin Electrophysiol 2010; 33: 1392-1406.
35. Huang X, Yang P, Du Y, et al. Age-related down-regulation of HCN channels in rat sinoatrial node. Basic Res Cardiol 2007; 102: 429-435. (Pubitemid 47278815)
36. Lompre AM, Lambert F, Lakatta EG, et al. Expression of sarcoplasmic reticulum Ca(2+)-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ Res 1991; 69: 1380-1388.
37. Taffet GE, Tate CA. CaATPase content is lower in cardiac sarcoplasmic reticulum isolated from old rats. Am J Physiol 1993; 264: H1609-H1614. (Pubitemid 23154151)
38. Koban MU, Moorman AF, Holtz J, et al. Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence. Cardiovasc Res 1998; 37: 405-423. (Pubitemid 28166001)
39. Williams BR, Kim J. Cardiovascular drug therapy in the elderly: theoretical and practical considerations. Drugs & aging 2003; 20: 445-463. (Pubitemid 36637087)
40. Bender AD. The effect of increasing age on the distribution of peripheral blood flow in man. J Am Geriatr Soc 1965; 13: 192-198.
41. Evans MA, Triggs EJ, Cheung M, et al. Gastric emptying rate in the elderly: implications for drug therapy. J Am Geriatr Soc 1981; 29: 201-205. (Pubitemid 11104620)
42. Podrazik PM, Schwartz JB. Cardiovascular pharmacology of aging. Cardiol Clin 1999; 17: 17-34. (Pubitemid 29140376)
43. Castleden CM, George CF. The effect of ageing on the hepatic clearance of propranolol. Br J Clin Pharmacol 1979; 7: 49-54. (Pubitemid 9096745)
44. Lamy PP. Comparative pharmacokinetic changes and drug therapy in an older population. J Am Geriatr Soc 1982; 30: S11-S19. (Pubitemid 13176474)
45. Novak LP. Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years. J Gerontol 1972; 27: 438-443.
46. Schwartz JB. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther 2007; 82: 87-96. (Pubitemid 46944201)
47. Cusack B, Kelly J, O'Malley K, et al. Digoxin in the elderly: pharmacokinetic consequences of old age. Clin Pharmacol Ther 1979; 25: 772-776. (Pubitemid 10192735)
48. Israili ZH, Dayton PG. Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab Rev 2001; 33: 161-235. (Pubitemid 32703255)
49. Campion EW, deLabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: report from the normative aging study. J Gerontol 1988; 43: M18-M20. (Pubitemid 18029934)
50. Greenblatt DJ. Reduced serum albumin concentration in the elderly: a report from the Boston collaborative drug surveillance program. J Am Geriatr Soc 1979; 27: 20-22. (Pubitemid 9111362)
51. Buxton ILO, Benet LZ. Pharmacokinetics: The dynamics of drug absorption, distribution, metabolism, and elimination. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th Edition; Brunton LL, Chabner BA, Knollman BC, eds.; McGraw-Hill, 2010; 17-40.
52. Klotz U. Antiarrhythmics: elimination and dosage considerations in hepatic impairment. Clin Pharmacokinet 2007; 46: 985-996. (Pubitemid 350136908)
53. Cheng JW, Frishman WH, Aronow WS. Updates on cytochrome p450-mediated cardiovascular drug interactions. Dis Mon 2010; 56: 163-179.
54. Kinirons MT, O'Mahony MS. Drug metabolism and ageing. J Br Menopause Soc 2004; 57: 540-544. (Pubitemid 38582172)
55. Tanaka E. In vivo age-related changes in hepatic drugoxidizing capacity in humans. J Clin Pharm Ther 1998; 23: 247-255. (Pubitemid 28532449)
56. Tateishi T, Fujimura A, Shiga T, et al. Influence of aging on the oxidative and conjugative metabolism of propranolol. Int J Clin Pharmacol Res 1995; 15: 95-101.
57. Miners JO, Penhall R, Robson RA, et al. Comparison of paracetamol metabolism in young adult and elderly males. Eur J Clin Pharmacol 1988; 35: 157-160.
58. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009; 41: 67-76.
59. Serste T, Bourgeois N. Ageing and the liver. Acta Gastroenterol Belg 2006; 69: 296-298. (Pubitemid 44807422)
60. Shi S, Klotz U. Age-related changes in pharmacokinetics. Curr Drug Metab 2011, [Epub ahead of print].
61. Vestal RE. Aging and determinants of hepatic drug clearance. Hepatology 1989; 9: 331-334. (Pubitemid 19063323)
62. Wynne H. Drug metabolism and ageing. J Br Menopause Soc 2005; 11: 51-56. (Pubitemid 40872876)
63. Aymanns C, Keller F, Maus S, et al. Review on pharmacokinetics and harmacodynamics and the aging kidney. Clin J Am Soc Nephrol 2010; 5: 314-327.
64. Muhlberg W, Platt D. Age-dependent changes of the kidneys: pharmacological implications. Gerontology 1999; 45: 243-253. (Pubitemid 29408280)
65. Lindeman RD. Changes in renal function with aging. Implications for treatment. Drugs & aging 1992; 2: 423-431.
66. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
67. Hu KT, Matayoshi A, Stevenson FT. Calculation of the estimated creatinine clearance in avoiding drug dosing errors in the older patient. Am J Med Sci 2001; 322: 133-136. (Pubitemid 32847824)
68. Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007; 5: 263-303. (Pubitemid 350048507)
69. Dai DF, Rabinovitch PS. Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med 2009; 19: 213-220.
70. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003; 107: 346-354. (Pubitemid 36135235)
71. Lipsitz LA. Orthostatic hypotension in the elderly. N Engl J Med 1989; 321: 952-957.
72. Parati G, Frattola A, Di Rienzo M, et al. Effects of aging on 24-h dynamic baroreceptor control of heart rate in ambulant subjects. Am J Physiol 1995; 268: H1606-H1612.
73. ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007; 14: 488-498.
74. Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26:181-186.
75. White M, Roden R, Minobe W, et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 1994; 90: 1225-1238. (Pubitemid 24284444)
76. th edition; Harzzard WR, Blass JP, Halter JB, et al., eds.; McGraw-Hill, 2003; 475-490.
77. Ali Raza J, Movahed A. Use of cardiovascular medications in the elderly. Int J Cardiol 2002; 85: 203-215. (Pubitemid 35245982)
78. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med 2000; 133: 687-695.
79. Fihn SD, Callahan CM, Martin DC, et al. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med 1996; 124: 970-979.
80. Palareti G, Hirsh J, Legnani C, et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. Arch Intern Med 2000; 160: 470-478. (Pubitemid 30112270)
81. Alves LE, Rose EP, Cahill TB Jr., et al. Disopyramide-induced urinary retention. Arch Intern Med 1984; 144: 2099. (Pubitemid 14021056)
82. Davidson E, Fuchs J, Rotenberg Z, et al. Drug-related syncope. Clin Cardiol 1989; 12: 577-580. (Pubitemid 19263177)
83. Tinetti ME. Clinical practice. Preventing falls in elderly persons. N Engl J Med 2003; 348: 42-49. (Pubitemid 36026346)
84. thedition; Brunton LL, Chabner BA, Knollman BC, eds.; McGraw-Hill, 2010.
85. Torres D, Parrinello G, Paterna S, et al. Severe brochostenosis by oral propafenone immediately after commencing treatment. Am J Ther 2011; [Epub ahead of print].
86. Griffith KA, Sherrill DL, Siegel EM, et al. Predictors of loss of lung function in the elderly: the cardiovascular health study. Am J Respir Crit Care Med 2001; 163: 61-68. (Pubitemid 32095254)
87. Eichhorn EJ, Gheorghiade M. Digoxin. Prog Cardiovasc Dis 2002; 44: 251-266. (Pubitemid 34438285)
88. Haynes K, Hennessy S, Localio AR, et al. Increased risk of digoxin toxicity following hospitalization. Pharmacoepidemiol Drug Saf 2009; 18: 28-35.
89. CAST-II-Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The cardiac arrhythmia suppression trial II Investigators. N Engl J Med 1992; 327: 227-233.
90. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 1991; 324: 781-788.
91. Hayes BD, Klein-Schwartz W, Barrueto F Jr. Polypharmacy and the geriatric patient. Clin Geriatr Med 2007; 23: 371-390. (Pubitemid 46621142)
92. th edition; Zipes DP, Jalife J, eds.; Saunders, 2009; 959-973.
93. Taira CA, Opezzo JA, Mayer MA, et al. Cardiovascular drugs inducing QT prolongation: facts and evidence. Curr Drug Saf 2010; 5: 65-72.
94. Trujillo TC, Nolan PE. Antiarrhythmic agents: drug interactions of clinical significance. Drug Saf 2000; 23: 509-532. (Pubitemid 32001513)
95. Caporaso NE, Shields PG, Landi MT, et al. The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype. Environ Health Perspect 1992; 98: 101-105. (Pubitemid 23061789)
96. Bailey DG, Dresser GK. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 2004; 4: 281-297. (Pubitemid 39429835)
97. Fromm MF, Kim RB, Stein CM, et al. Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [see comments]. Circulation 1999; 99: 552-557. (Pubitemid 29061872)
98. Abel S, Nichols DJ, Brearley CJ, et al. Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide. Br J Clin Pharmacol 2000; 49: 64-71. (Pubitemid 30050488)
99. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med 2007; 356: 935-941.
100. Mustafa SJ, Morrison RR, Teng B, et al. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol 2009: 161-188.
101. Shen WK, Kurachi Y. Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiology. Mayo Clin Proc 1995; 70: 274-291.
102. Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 1997; 79: 2-10. (Pubitemid 27305162)
103. Marcum ZA, Handler SM, Boyce R, et al. Medication misadventures in the elderly: a year in review. Am J Geriatr Pharmacother 2010; 8: 77-83.